Heather Francis
Indiana University
Appearances
DateMay 9, 2023BACKGROUND: Alcoholic hepatitis (AH) is a life-threatening form of alcohol-associated liver disease (ALD), with no effective therapy…- DateMay 6, 2023BACKGROUND: Chronic cholestatic liver diseases, such as primary sclerosing cholangitis (PSC), often lead to end-stage liver disease requiring liver transplantation. PSC also significantly increases the risk of cholangiocarcinoma (CCA)…
- DateMay 8, 2023AIMS: The mechanism of gut microbiota involved in the etiopathogenesis of primary cholangitis (PBC) remains unclear. Here, we investigated the role of gut microbiota in liver immune response in PBC…
- DateMay 8, 2023AIMS: The mechanism of gut microbiota involved in the etiopathogenesis of primary cholangitis (PBC) remains unclear. Here, we investigated the role of gut microbiota in liver immune response in PBC…
- DateMay 8, 2023AIMS: The mechanism of gut microbiota involved in the etiopathogenesis of primary cholangitis (PBC) remains unclear. Here, we investigated the role of gut microbiota in liver immune response in PBC…
DateMay 20, 2024SOCIETY: AASLDModerators
University of PittsburghIndiana University
DateMay 21, 2024SOCIETY: AGA/AASLDModerators
Indiana UniversityUniversity of Arkansas for Medical Sciences
DateMay 18, 2024METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITISModerators
Indiana UniversityUniversity of Southern CaliforniaSpeakers
University of Nevada Las Vegas School of Medicine
